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To assess patients’ utilities for health state outcomes after transhiatal or transthoracic oesophagectomy for oesophageal cancer
and to investigate the patients’ treatment preferences for either procedure. The study group consisted of 48 patients who had
undergone either transhiatal or transthoracic oesophagectomy. In an interview they were presented with eight possible health
states following oesophagectomy. Visual Analogue Scale and standard gamble techniques were used to measure utilities.
Treatment preference for either transhiatal or transthoracic oesophagectomy was assessed. Highest scores were found for the
patients’ own current health state (Visual Analogue Scale: 0.77; standard gamble: 0.97). Lowest scores were elicited for the
health state ‘irresectable tumour’ (Visual Analogue Scale: 0.13; standard gamble: 0.34). The Visual Analogue Scale method
produced lower estimates (P50.001) than the standard gamble method for all health states. Most patient characteristics and
clinical factors did not correlate with the utilities. Ninety-ﬁve per cent of patients who underwent a transthoracic procedure
and 52% of patients who underwent a transhiatal resection would prefer the transthoracic treatment. No signiﬁcant
associations between any patient characteristics or clinical characteristics and treatment preference were found. Utilities after
transhiatal or transthoracic oesophagectomy were robust because they generally did not vary by patient or clinical
characteristics. Overall, most patients preferred the transthoracic procedure.
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In Western countries, carcinoma of the oesophagus is a relatively
uncommon tumour. It disseminates early and most patients
present with advanced disease. When cure can be expected,
surgical resection is the therapeutic modality of ﬁrst choice
(Akoh and McIntyre, 1992; Devesa et al, 1998). Curative oeso-
phageal resection may be carried out by either a transhiatal or
transthoracic technique (Tilanus et al, 1993). The ﬁrst strategy
aims to decrease early post-operative morbidity and mortality
by limiting the extent of the operation. The other strategy aims
at improving the cure rate by performing a more radical resec-
tion.
Regardless of the surgical approach, oesophageal resection is a
major operation. It is associated with severe physical and emotional
effects and it may thus seriously affect the patient’s quality of life.
Both types of operation are accompanied by an extended hospital
stay with possible postoperative morbidity such as respiratory
infections. Afterwards, patients may face a lengthy recovery period,
severe side effects of the intervention and the threat of recurrent
disease. Recognising this health burden, researchers are increasingly
studying the quality of life of these patients (Gelfand and Finley,
1994; Blazeby et al, 2000).
To evaluate the cost-effectiveness of both surgical strategies,
patients’ utilities for the outcome health states of oesophageal
cancer associated with either transhiatal or transthoracic surgery
are needed (Gold et al, 1996; Weinstein et al, 1996). Utilities range
from 0 (death) to 1 (perfect health) and patients are typically asked
to assign a value to their own current health state or to other
potential outcomes of treatment. To our knowledge, utilities for
potential health state outcomes of oesophageal cancer have never
been assessed.
Apart from the inclusion of patient utilities, the explicit choice
of patients for a particular treatment should also be taken into
account when deciding which treatment to choose. These choices
are known as treatment preferences and typically involve informed
patients (de Haes and Stiggelbout, 1996; Keulemans et al, 1998;
Nieuwkerk et al, 1998; Awad et al, 2000). The treatment preference
method is a realistic reﬂection of the actual decision situation.
Therefore, this method is especially useful to support the decision
analysis.
The objectives of this study were: (1) to assess patients’ utilities
for health state outcomes after oesophagectomy of patients who
had undergone either transhiatal or transthoracic resection and
to explore how patient characteristics and clinical factors inﬂuence
these utilities; (2) to investigate the treatment preferences of the
patients for either transhiatal oesophagectomy or transthoracic
oesophagectomy in the treatment of oesophageal cancer and to
explore how various patient characteristics and clinical factors
inﬂuence these treatment preferences.
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Patients
Between January 1997 and March 1999, 93 consecutive patients
with adenocarcinoma of the oesophagus or oesophagogastric junc-
tion were asked to participate in the present study. All patients
took part in a randomised clinical trial comparing transhiatal oeso-
phagectomy vs transthoracic oesophagectomy with two-ﬁelds
lymphadenectomy (Van Sandick et al, 1998). The study was
performed in two academic centres (Academic Medical Center/
University of Amsterdam and University Hospital Dijkzigt-Rotter-
dam). In both centres, the study was approved by the institutional
medical ethics committee. All patients were provided written
informed consent at study entry.
Inclusion criteria were: (1) age 4= 18 years; (2) invasive adeno-
carcinoma of the middle or distal oesophagus or oesophagogastric
junction and (3) locally resectable disease without distant metas-
tases on preoperative investigations. Exclusion criteria were: (1) a
previous diagnosis of other malignant disease; (2) organ insufﬁ-
ciency as deﬁned by ASA III or IV (American Society of
Anaesthesiology) (Owens et al, 1978); (3) impossibility to construct
a gastric tube and (4) previous chemotherapy, radiation therapy or
immunotherapy. Oesophageal resection was performed by a trans-
hiatal approach without thoracotomy or via a right-sided
thoracotomy in combination with a laparotomy. Gastro-intestinal
continuity was usually re-established by constructing a gastric tube.
In all patients, the anastomosis was performed in the neck.
Interview
Patients were interviewed at the outpatient’s clinic when the
patient was scheduled for a follow-up visit. Patients with irresect-
able disease at the time of operation and those with recurrent
cancer were excluded from the interview, because of possible
emotional burden. Interviews took place 3–12 months after the
operation, to optimise the chance that patients were in a stable
situation with near-maximal functional recovery. All interviews
were performed by one of two trained interviewers between May
1997 and October 1998. On average, the interview lasted 58 (range
35–140) min.
Health state descriptions
Seven health state descriptions of possible outcomes after a transhia-
tal or transthoracic resection for oesophageal cancer were constructed
(Figure 1). The health state scenarios employed short phrases to
convey information on speciﬁc areas of physical, emotional and
social functioning. The areas included: (1) mobility; (2) disease free
or recurrent disease; (3) pain; (4) hoarseness; (5) tiredness; (6) pneu-
monia (yes/no); (7) swallowing and number of meals; (8)
psychological problems, and (9) social support. Using the patient’s
own gender, i.e. ‘he’ for men and ‘she’ for women, each description
was read to the patient by the interviewer in random order and
repeated on request. Also included in the interview was a description
of the patient’s own current health state. For this description, patients
were asked to think about their physical, emotional and social health
state of the past week. During the interview, patients were ﬁrst asked
to rank all health state descriptions including their own from 1 ‘best
health state’ to 8 ‘worst health state’. Then, they were asked to assign
utilities to the health state descriptions with either the visual analogue
scale or standard gamble method and to indicate their treatment
preference, as described below.
Visual analogue scale (VAS)
A Visual Analogue Scale (VAS) was used as the initial method by
which values were elicited for the patient’s own current health state
and the above mentioned health state descriptions. The VAS is a
100 mm horizontal line. The anchors were ‘worst imaginable
health’ at zero and ‘perfect health’ at 100. Each subject was asked
to sign a cross on the VAS for each health state. This method is
easy to understand (Stiggelbout et al, 1996), but the scores
produced are often not regarded as true utilities, because there is
no risk involved.
Standard gamble
The standard gamble is regarded as the gold standard for eliciting
individual utilities because it is based on solid theoretical founda-
tions and it involves risk (Gold et al, 1996). In the standard gamble
procedure the patients are asked to choose between a certain-but-
imperfect health state and a gamble between perfect health and
death. In the gamble there is a probability, ‘p’, of living in perfect
health and a probability, ‘1-p’, of death within a week. The value of
‘p’ at which the participant is indifferent between the gamble and a
certain health state is the utility of that certain health state.
In this part of the interview, patients were introduced to a
‘chance board’ used to elicit standard gamble utilities. Probabilities
for the gamble were presented in a ‘ping-pong’ fashion, beginning
with a 100% chance of ‘perfect health’ and a 0% chance of
‘immediate death’, followed by 0% chance of ‘perfect health’ and
a 100% chance of ‘immediate death’, followed by a 95% chance
of ‘perfect health’ and a 5% chance of ‘immediate death’, and so
on until the participant reported indifference between the gamble
and the certain health state outcome.
Treatment preference
In order to elicit treatment preference, the interviewer ﬁrst
repeated the information about both the transhiatal and the trans-
thoracic procedures that was given to the patient as part of the
informed consent procedure prior to the study inclusion. This
information included: ‘It is unknown which of the two procedures
is best. Theoretically, the advantage of the transhiatal method is
that recovery after the operation might be quicker. The advantage
of the transthoracic procedure might be that the tumour might be
removed better as well more lymph nodes which might be affected
by the tumour. Therefore the course of the disease might be more
favourable. Disadvantage of the transthoracic procedure is that an
extra wound is needed and that during the ﬁrst part of the opera-
tion the function of the right lung will be temporarily eliminated.’
After reading this information, patients were asked to imagine a
neighbour or friend with an oesophageal tumour who had to be
operated upon, and to choose the preferred treatment for this
other patient.
Additional measures
All patients received a self-report questionnaire prior to the opera-
tion. The questionnaire included questions on marital status,
having children, and education (primary school, high-school or
college). During hospitalisation, clinical data were registered
including (1) pneumonia, (2) other respiratory complications, (3)
anastomotic leakage, (4) cardiac complications, (5) wound infec-
tion, (6) chylothorax, (7) ventilation time in days, (8) intensive
care unit (ICU) stay in days, and (9) hospital stay in days.
Statistical analysis
All data were checked for accuracy and analysed using the Statisti-
cal Package for the Social Sciences (SPSS-10.0). VAS scores did
show a normal distribution and therefore parametrical tests were
performed for VAS data. None of the standard gamble data
followed a normal distribution as judged by graphical assessment
and the Kolmogorov–Smirnov test for normality, nor was it possi-
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Figure 1 Possible outcome health states after oesophagectomy for oesophageal cancer.
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used non-parametric tests for these data.
Differences in clinical data between the THE and TTE group
were tested with the Mann–Whitney U statistic. For each health
state, a Wilcoxon’s matched pairs test was used for comparing
mean utilities produced by the VAS and standard gamble methods.
To determine whether the utilities of the individual health states
were signiﬁcantly different from each other, we used the repeated
measures ANOVA and t-tests for the VAS utilities, and Friedman
tests and Wilcoxon tests for the standard gamble utilities.
To determine whether patient characteristics were related to
utilities, Spearman’s rank correlations were calculated between
utility scores and patient characteristics (gender, marital status,
having children, education, age and months of follow-up when
interviewed). To test for differences in utilities between patients
with either transhiatal of transthoracic procedure and between
patients with and without complications, one-way ANOVA was
performed for VAS scores and Mann–Whitney U-test for standard
gamble scores. The relationship between utilities and clinical data
was further explored by correlating both VAS scores (Pearson
correlations) and standard gamble scores (Spearman correlations)
with length of ventilation, length of ICU stay and length of hospital
stay.
To test for differences in treatment preferences between the two
surgical groups, patient characteristics were tested with the w
2-test
(gender, marital status, having children and education) or Spear-
man’s rank correlations (age and months of follow-up when
interviewed). Additionally, the effect of having experienced compli-
cations on subsequent treatment preference was evaluated by
means of the w
2 statistic.
P-values 50.05 were considered statistically signiﬁcant. Follow-
ing recommendations of Cohen, correlations will be considered low
if r50.20, moderate if 0.205=r5=0.50 or high if r40.50 (Cohen,
1977). Only signiﬁcant correlations are reported.
RESULTS
Patients
Of the 93 patients who consented to participate, four (4%) patients
had deceased in the hospital and nine (10%) patients had died
before the interview because of recurrent disease. Furthermore,
21 (23%) patients were still alive but were excluded because of
recurrent disease. Of the remaining 59 patients, six (10%) ulti-
mately refused participation because of emotional burden and
three (5%) could not be reached. Therefore, 50 patients were inter-
viewed (85%).
Of the interviewed patients, 26 (52%) patients underwent the
THE procedure and 24 (48%) patients underwent the TTE proce-
dure. Twenty (47%) of the excluded patients underwent the THE
procedure and 23 (53%) the TTE procedure.
Data of two interviewed patients were excluded because of erra-
tic data collection and because of cognitive problems with the
standard gamble, resulting in 48 evaluable cases. Most patients
were male (90%), married (86%), had children (91%), and had
ﬁnished high-school (45%) or college (20%). The average age
was 63 years (44–79 years) and average time of follow-up when
interviewed was 7 months (3–12 months) after the operation.
Clinical data of both THE and TTE groups are reported in Table
1. Pneumonia and respiratory infections were signiﬁcantly less
frequent after transhiatal resection than after transthoracic resec-
tion (P=0.04 and 0.005, respectively).
Utilities
The ranking and the VAS and standard gamble scores of the seven
possible health states and the ‘own current health’ are given in
Table 2. Highest ranking and utility scores were found for the
patients’ own health state. Regarding the possible health states,
highest ranking and highest VAS and standard gamble scores were
given for the disease free health state while lowest ranking and
utilities were elicited for the health state involving an irresectable
tumour.
The VAS method produced lower estimates than the standard
gamble method for all health states (all P50.001). A signiﬁcant
overall difference was found among the health state utilities for
each assessment method (both ANOVA repeated measures and
the Friedman test (P50.001)). This would indicate that at least
one health outcome state was distinct from one of the others in
each elicitation method. Regarding the VAS scores, results of the
t-tests showed most health states were distinct from each other.
However, no difference was found between the own current health
state and the disease free health state (P=0.82), between the health
states ‘recovering at home’ and ‘hospitalisation without complica-
tions’ (P=0.67), and between the health states ‘recurrent disease
in gastric tube’ and ‘recurrent disease in bones’ (P=0.15). For the
standard gamble scores, results of the Wilcoxon test showed that
again most health state valuations were different from each other.
No differences were found between own current health state and
‘disease free health’ (P=0.11), between the health states ‘recovering
at home’ and ‘hospitalisation without complications’ (P=0.22), and
between the health states ‘recurrent disease in bones’ and ‘irresect-
able tumour’ (P=0.51).
Utilities and patient characteristics
No signiﬁcant correlations were found between marital status,
education or months of follow-up on the one hand and utility
scores for any health state on the other. Moderate correlations were
found between female gender and standard gamble score for ‘recur-
rent disease in gastric tube’ (r=0.32), between having children and
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Table 1 Clinical data on 48 patients who underwent transhiatal oeso-
phagectomy (THE) or transthoracic oesophagectomy with two-ﬁelds
lymphadenectomy
THE TTE Total
(n=26) (n=22) (n=48)
Pneumonia 2 7 9
Respiratory complications 5 13 18
Clinical anastomotic leakage (salivary ﬁstula) 7 5 12
Cardiac complications 2 4 6
Wound infection 2 4 6
Chylothorax 0 1 1
Ventilation in days (median; range) 1 (0–8) 3 (1–22) 1 (0–22)
ICU stay in days (median; range) 2 (1–17) 7 (2–37) 4 (1–37)
Hospital stay in days (median; range) 18 (11–38) 20 (12–64) 18 (11–64)
Table 2 Ranking, mean VAS scores and mean standard gamble scores
for the patients’ own current health state and seven possible health states
VAS Standard
Rank mean gamble
Health state median (s.d.) mean (s.d.) P-value*
Own current health 1 0.77 (0.14) 0.97 (0.06) 50.001
A (home, disease free) 2 0.77 (0.12) 0.96 (0.07) 50.001
B (home, recovering) 3 0.56 (0.18) 0.92 (0.15) 50.001
C (hospital, no complications) 4 0.55 (0.17) 0.90 (0.15) 50.001
D (hospital, pneumonia) 5 0.40 (0.17) 0.82 (0.25) 50.001
E (recurrence in gastric tube) 6 0.19 (0.16) 0.41 (0.31) 50.001
F (recurrence in bones) 7 0.17 (0.15) 0.35 (0.30) 50.001
G (irresectable) 8 0.13 (0.16) 0.34 (0.31) 50.001
*t-test between VAS and standard gamble utilities.
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‘irresectable tumour’ (r=0.33), and between higher age and the
standard gamble score for ‘hospitalisation without complications’
(r=0.40).
Utilities and clinical characteristics
As depicted in Table 3, there were no statistically signiﬁcant differ-
ences between patients who had undergone either the transhiatal or
the transthoracic procedure in either VAS or standard gamble
scores of any health states. In addition, the experience of post-
operative complications had no signiﬁcant effect on the utility
scores for any of the seven health state scenarios. Length of ventila-
tion, length of ICU stay and length of hospital stay were not
signiﬁcantly associated with either VAS or standard gamble utility
scores on any health states.
Treatment preference
In Table 4 the treatment preferences are reported. The great major-
ity of patients (21 out of 22) who underwent a transthoracic
procedure would recommend the same procedure for another
patient. However, half of the patients (12 out of 25) who under-
went a transhiatal resection would not recommend a transhiatal
procedure but transthoracic surgery. No signiﬁcant associations
between any patient characteristics or clinical factors and treatment
preference were found.
DISCUSSION
The main objective of this study was to assess patients’ utilities for
different outcomes after oesophagectomy by using a clinically rele-
vant study population. We found that patients were able to order
the presented health states as anticipated by the degree of described
impairment in physical, emotional and social functioning and to
provide VAS and standard gamble scores. The valuations they
provided were of similar magnitude as utilities found in earlier
research on cancer patients. Ness et al (1999) measured standard
gamble scores for outcome states of colorectal cancer in a sample
of 81 patients who had previously undergone resection of colorec-
tal carcinoma. They found standard gamble scores of 0.84 for ‘own
health’, 0.74 for the health state ‘disease free after resection’ and
0.25 for ‘metastatic/irresectable’. For these health states, we
measured standard gamble utilities of 0.97, 0.96 and 0.34, respec-
tively. In a study by Stiggelbout et al (1994), 30 disease free
testicular cancer patients were interviewed with the standard
gamble technique. They found a mean standard gamble score of
0.93 for the health state ‘disease free after orchidectomy’, which
is similar to the 0.96 standard gamble utility we found for ‘disease
free after oesophagectomy’. Our ‘own current health state’ VAS
and standard gamble scores of 0.77 and 0.97 were also comparable
with those of other chronic diseases: 0.68 and 0.91 for asthma
(Blumenschein and Johannesson, 1998) and 0.81 and 0.92 for angi-
na (Lalonde et al, 1999).
We consistently found signiﬁcantly lower VAS scores as
compared to standard gamble scores for the same health states.
This is a well-known phenomenon (Froberg and Kane, 1989; Bass
et al, 1994; de Haes and Stiggelbout, 1996) possibly caused by risk
aversion (Froberg and Kane, 1989) or biased risk perception (De
Haes and Stiggelbout, 1996). Risk aversion refers to the conserva-
tism most people experience with respect to risk taking, while the
effect of risk perception refers to an overestimation of low percen-
tages. Both effects might lead to higher standard gamble utility
values.
In this study, most health state valuations were found to be
statistically distinct from each other. However, with both VAS
and standard gamble techniques, no difference was found between
own current health state and the disease free health state nor
between the health states recovering at home and hospitalisation
without complications. On the one hand, it was expected that
the patients’ own health state and a disease free health state would
be valued similarly, because most patients were in a disease free
health state after maximal rehabilitation at the time of the inter-
view. On the other hand, people tend to value their own health
state more positively than a similar possible one (Jansen et al,
2000). However, this last discrepancy did not occur in our study.
It was surprising that the utilities for ‘recovering at home’ and
‘in hospital after an oesophagectomy without complications’ were
not distinct. We expected that patients are in a better health state
at home than in hospital and that they would also prefer to be at
home. It might be possible that the recovery at home after such a
major operation is physically and mentally very demanding and is
much more difﬁcult than the patients had anticipated. It is of clin-
ical interest that we did ﬁnd a distinction between the two health
states ‘hospitalisation without complications’ and ‘hospitalisation
with pneumonia’. Signiﬁcantly less patients suffer from pneumonia
after transhiatal resection than after transthoracic resection (Van
Sandick et al, 1998). Therefore, these different valuations might
exert an effect in a cost-utility analysis comparing both treatments.
The utilities we found in our study were robust, because they
were hardly inﬂuenced by patient or clinical characteristics such
as age or respiratory complications. Several other studies have
investigated the effect of patient or clinical factors on utilities.
No evident effect of these factors on utility scores was found in
these studies either. For example, in a study of 82 psoriasis
patients, no patient characteristics and indicators of disease severity
were predictive of utilities for the assessed health states (Zug et al,
1995). Standard gamble values of diabetic patients were found to
be inﬂuenced by gender (Brown et al, 1999), but not by education
or vision loss. In stroke patients (Hallan et al, 1999), only two of
11 parameters (marital status and age) showed a signiﬁcant effect
on SG scores. In a study of 51 HIV patients (Tsevat et al, 1999),
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Table 3 Mean VAS scores and standard gamble scores for the patients’
own health state and seven possible health states after either transhiatal
(THE) or transthoracic (TTE) oesophagectomy
VAS
a Standard gamble
b
THE TTE THE TTE
Health state patients patients patients patients
Own current health 0.76 0.77 0.98 0.97
A (home, disease free) 0.77 0.78 0.97 0.96
B (home, recovering) 0.51 0.61 0.91 0.93
C (hospital, no complications) 0.52 0.58 0.90 0.91
D (hospital, pneumonia) 0.38 0.42 0.80 0.86
E (recurrence in gastric tube) 0.19 0.20 0.41 0.42
F (recurrence in bones) 0.19 0.14 0.35 0.35
G (irresectable) 0.11 0.16 0.30 0.39
aOne-way Anova, no signiﬁcant differences between groups;
bMann–Whitney U,n o
signiﬁcant differences between groups.
Table 4 Treatment preference of 47 patients for either transhiatal
oesophagectomy (THE) or transthoracic oesophagectomy with two-fields
lymphadenectomy (TTE)
Treatment preference
Received treatment THE TTE Total
THE 13 12 25
TTE 1 21 22
Total 14 33 47*
*Data missing for one patient.
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found, but 15 other variables had no effect on utility.
The fact that we barely found a relation between utilities and
other factors could be caused by the fact that many characteristics
did not show an even distribution of outcomes: most patients were
male, older, married and had children. Furthermore, we examined
a relatively small sample of patients and most patients did not have
any severe complications during hospitalisation. However, the lack
of effect of background factors on utility scores is so consistent in
the literature, that it is probable that people base their valuations
on the possible health state descriptions and are not inﬂuenced
by background characteristics.
With regard to the treatment preference, half of the patients
who underwent the transhiatal procedure would not choose their
own treatment again, but the transthoracic treatment instead.
However, almost all patients who underwent the transthoracic
procedure would choose the extensive procedure again. This is a
remarkable result, because earlier studies (Keulemans et al, 1998;
Nieuwkerk et al, 1998) showed that people tend to choose the
treatment they have received, even if this treatment was randomly
allocated. In the present study, patients apparently want to opti-
mise the chances that the malignant disease is deﬁnitely cured.
They are prepared to undergo an even more demanding procedure
to increase their chances in the long term. This preference for the
transthoracic procedure might be biased by the informed consent
information given to the patients. The information is based on
the assumption that the transthoracic procedure might lead to
favourable outcomes in the long term. However, this hypothesis
is still being investigated.
One problem of the present study relates to the number of
excluded patients which was over half the patients. Although the
percentage of patients undergoing the transhiatal or transthoracic
procedure was the same in the interviewed and excluded patients,
the exclusion of patients with the worst postoperative course (in-
hospital deaths and recurrence within the ﬁrst year) might have
biased the data. The health state utilities and treatment preferences
might therefore not be generalised to all oesophagectomy patients,
but only to the patients who survived the ﬁrst year after the opera-
tion.
In conclusion, we have obtained speciﬁc estimates of utility
values that patients would assign to outcomes after transhiatal or
transthoracic oesophagectomy. We have also demonstrated that
these robust utilities, either derived by VAS or by standard gamble
techniques, generally do not vary signiﬁcantly by patient and clin-
ical characteristics. Finally, we have found that most patients would
prefer the extended transthoracic procedure. These results should
be incorporated into decision analysis and evaluation of cost-effec-
tiveness of surgical procedures for oesophageal cancer.
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